Literature DB >> 15451542

A possibility to predict the absorbability of poorly water-soluble drugs in humans based on rat intestinal permeability assessed by an in vitro chamber method.

Etsushi Watanabe1, Masayuki Takahashi, Masahiro Hayashi.   

Abstract

This paper describes a means to predict the absorbability of poorly water-soluble drugs in humans based on rat intestinal permeability assessed by the in vitro Ussing-type chamber method. We investigated the correlation between the apparent permeability coefficients (P(app)) of 10 water-soluble drugs obtained by the in vitro chamber method, in which the excised rat small intestinal tissue was used as the membrane, and the fractions absorbed (F(a)) in humans. Using this correlation, we predicted F(a) values of 5 poorly water-soluble drugs based on their P(app) obtained through our modified chamber method using an additive. For water-soluble drugs, a good correlation between P(app) and F(a') expressed by the equation: F(a) = 1 - exp(-P(app) x 1.51 x 10(5))(r(2) = 0.920), was found. The poorly water-soluble drugs used in the present study could be solubilized with 5% (final concentration) dimethylsulfoxide, and their P(app) could be obtained through our modified chamber method. For poorly water-soluble drugs whose dose:solubility ratio ranged from 2500 to 3500 ml, predicted F(a) values were favorably comparable with their F(a) values reported in humans in the literature. These results showed that the in vitro Ussing-type chamber method was a useful method for predicting the F(a) of poorly water-soluble drugs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15451542     DOI: 10.1016/j.ejpb.2004.03.029

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  8 in total

Review 1.  Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.

Authors:  Xianhua Cao; Seth T Gibbs; Lanyan Fang; Heather A Miller; Christopher P Landowski; Ho-Chul Shin; Hans Lennernas; Yanqiang Zhong; Gordon L Amidon; Lawrence X Yu; Duxin Sun
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

2.  Differential effect of oxidative stress on intestinal apparent permeability of drugs transported by paracellular and transcellular route.

Authors:  Pankaj Dixit; Dinesh Kumar Jain; Jaypal Singh Rajpoot
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-06-21       Impact factor: 2.441

3.  Development of hydrophobized alginate hydrogels for the vessel-simulating flow-through cell and their usage for biorelevant drug-eluting stent testing.

Authors:  Beatrice Semmling; Stefan Nagel; Katrin Sternberg; Werner Weitschies; Anne Seidlitz
Journal:  AAPS PharmSciTech       Date:  2013-08-06       Impact factor: 3.246

4.  Permeabilities of rebamipide via rat intestinal membranes and its colon specific delivery using chitosan capsule as a carrier.

Authors:  Bei-Bei Huang; Guo-Feng Li; Jing-Hui Luo; Lian Duan; Kishimoto Nobuaki; Yamamoto Akira
Journal:  World J Gastroenterol       Date:  2008-08-21       Impact factor: 5.742

5.  Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (Lipomer) using Box Behnken design.

Authors:  Balaram Gajra; Chintan Dalwadi; Ravi Patel
Journal:  Daru       Date:  2015-01-21       Impact factor: 3.117

6.  In vitro determination of drug transfer from drug-coated balloons.

Authors:  Anne Seidlitz; Nadine Kotzan; Stefan Nagel; Thomas Reske; Niels Grabow; Claus Harder; Svea Petersen; Katrin Sternberg; Werner Weitschies
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

7.  Metformin hydrochloride entrapment in sorbitan monostearate for intestinal permeability enhancement and pharmacodynamics.

Authors:  Omar Y Mady; Adam A Al-Shoubki; Ahmed A Donia; Waseem Qasim
Journal:  Sci Rep       Date:  2021-10-11       Impact factor: 4.379

8.  Using Ex Vivo Porcine Jejunum to Identify Membrane Transporter Substrates: A Screening Tool for Early-Stage Drug Development.

Authors:  Yvonne E Arnold; Yogeshvar N Kalia
Journal:  Biomedicines       Date:  2020-09-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.